Cargando…

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study

BACKGROUND: The complement system is involved in pathogenesis of cardiovascular disease, and might play a role in accelerated atherogenesis in spondylarthropathies (SpA). Hence, we examined complement activation in SpA, and its relationship to antirheumatic treatment, inflammatory and cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hokstad, Ingrid, Deyab, Gia, Wang Fagerland, Morten, Lyberg, Torstein, Hjeltnes, Gunnbjørg, Førre, Øystein, Agewall, Stefan, Mollnes, Tom Eirik, Hollan, Ivana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650069/ https://www.ncbi.nlm.nih.gov/pubmed/31335881 http://dx.doi.org/10.1371/journal.pone.0220079

Ejemplares similares

Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
por: Hokstad, Ingrid, et al.
Publicado: (2022)

Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
por: Deyab, Gia, et al.
Publicado: (2017)

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
por: Nguyen, Thao H. P., et al.
Publicado: (2022)

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Deyab, Gia, et al.
Publicado: (2017)

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
por: Deyab, Gia, et al.
Publicado: (2021)

Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
por: Nguyen, Thao H. P., et al.
Publicado: (2021)

Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases
por: Shields, Kelly J., et al.
Publicado: (2017)

Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial
por: Kåss, Anita, et al.
Publicado: (2015)

Collagenous Colitis and Spondylarthropathy
por: Ben Abdelghani, Kaouther, et al.
Publicado: (2012)

The alternative complement pathway revisited
por: Harboe, Morten, et al.
Publicado: (2008)

High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis
por: Nguyen, Thao H. P., et al.
Publicado: (2023)

Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study
por: Kåss, AS, et al.
Publicado: (2014)

Complement Activation in 22q11.2 Deletion Syndrome
por: Grinde, Dina, et al.
Publicado: (2020)

Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
por: Smedbråten, Julia, et al.
Publicado: (2016)

Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis
por: Oma, Ingvild, et al.
Publicado: (2018)

Editorial: The Role of Complement in Health and Disease
por: Cedzyński, Maciej, et al.
Publicado: (2019)

Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity
por: Toussirot, Éric, et al.
Publicado: (2009)

OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
por: Krystufkova, O, et al.
Publicado: (2003)

The Role of Complement in Liver Injury, Regeneration, and Transplantation
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2019)

Chronic, eventually fatal, Kawasaki-like disease in an adult with spondylarthropathy responding to IVIG therapy
por: Soltner, Elise, et al.
Publicado: (2009)

Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies
por: van der Weijden, M. A. C., et al.
Publicado: (2010)

Immune cell transcript modules reveal leukocyte heterogeneity in synovial biopsies of seronegative spondylarthropathy patients
por: Hallett, Robin M, et al.
Publicado: (2014)

Linking genotype to cell function in chronic inflammation: analysis of the IL-23/Th17 axis in spondylarthropathy
por: Roumier, M, et al.
Publicado: (2010)

Inflammatory cell infiltrates in the heart of patients with coronary artery disease with and without inflammatory rheumatic disease: a biopsy study
por: Andersen, Jacqueline K., et al.
Publicado: (2016)

Increased complement activation 3 to 6 h after trauma is a predictor of prolonged mechanical ventilation and multiple organ dysfunction syndrome: a prospective observational study
por: Rognes, Ingrid Nygren, et al.
Publicado: (2021)

A role for the terminal C5-C9 complement pathway in idiopathic pulmonary fibrosis
por: Sikkeland, Liv I. B., et al.
Publicado: (2023)

Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies
por: Miceli-Richard, Corinne, et al.
Publicado: (2009)

Inflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases: Data From the Oslo-CoMet Trial
por: Fretland, Asmund Avdem, et al.
Publicado: (2015)

Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
por: Cyranka, Leon, et al.
Publicado: (2023)

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
por: Garred, Peter, et al.
Publicado: (2021)

High mobility group box-1 protein – one step closer to the clinic?
por: Mollnes, Tom Eirik
Publicado: (2008)

Bacteria in the Adventitia of Cardiovascular Disease Patients with and without Rheumatoid Arthritis
por: Curran, Samuel A., et al.
Publicado: (2014)

Clinical and Complement Long-Term Follow-Up of a Pediatric Patient with C3 Mutation-Related Atypical Hemolytic Uremic Syndrome
por: Bjerre, Anna, et al.
Publicado: (2018)

Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets
por: Barratt-Due, Andreas, et al.
Publicado: (2017)

Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood
por: Landsem, Anne, et al.
Publicado: (2022)

Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy
por: Paunas, Teodora Ioana Flavia, et al.
Publicado: (2017)

The alternative complement pathway is dysregulated in patients with chronic heart failure
por: Shahini, Negar, et al.
Publicado: (2017)

Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement
por: Zhang, Jie, et al.
Publicado: (2020)

A porcine model of hemodialyzer reactions: roles of complement activation and rinsing back of extracorporeal blood
por: Pethő, Ákos, et al.
Publicado: (2021)

The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation
por: Hetland, Geir, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_prm9d14dtggm425tm655k2rstg